Opportunity
Federal Register #1117-0056
DEA Proposes Centralized Reporting for Suspicious Orders of Controlled Substances
Buyer
Drug Enforcement Administration (DEA)
Posted
July 29, 2026
Respond By
September 28, 2026
Identifier
1117-0056
This opportunity concerns a proposed information collection by the Drug Enforcement Administration (DEA) for reporting suspicious orders of controlled substances. - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - Purpose: - Establishment of a centralized database for reporting suspicious orders of controlled substances - Required by Section 307 of the Controlled Substances Act (21 U.S.C. 827) - Supports a closed system of distribution and compliance with international treaty obligations - Scope: - Involves 178 registrants - Estimated annual burden: 12,324 hours - No OEMs or vendors are specified, as this is not a procurement of products or services - The DEA is seeking public comments on the necessity, accuracy, and burden of the proposed collection - No products, part numbers, or quantities are being requested; this is an information collection activity only
Description
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), is proposing a new information collection request titled 'Suspicious Orders of Controlled Substances'. This collection involves a centralized database for reporting suspicious orders of controlled substances to ensure a closed system of distribution and compliance with international treaty obligations. The DEA estimates 178 registrants will participate, with an estimated total annual burden of 12,324 hours. Public comments are requested and will be accepted for 60 days until September 28, 2026.